Fremanezumab (TEV-48125) is a humanized IgG2a monoclonal antibody that selectively and potently binds to calcitonin gene-related peptide (CGRP). CGRP is a 37-amino acid neuropeptide involved in central and peripheral pathophysiological events of migraine. Fremanezumab has the potential for chronic migraine research.
Purity:
>95.0%
CAS Number:
[1655501-53-3]
* VAT and and shipping costs not included. Errors and price changes excepted
